Diagnamed Holdings Corp. (CSE:DMED)
Canada · Delayed Price · Currency is CAD 0.0650
0.00 (0.00%)
At close: Feb 9, 2026
Diagnamed Holdings Company Description
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions.
The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders.
It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water.
Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
Diagnamed Holdings Corp.
| Country | Canada |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | John Karagiannidis |
Contact Details
Address: 82 Richmond Street East Toronto, ON M5C 1P1 Canada | |
| Phone | 416 800 2684 |
| Website | diagnamed.com |
Stock Details
| Ticker Symbol | DMED |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| ISIN Number | CA25245D1033 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| John Karagiannidis | President, Chief Executive Officer and Director |
| Andre Turmel | Independent Executive Chairman |
| Edward Low | Chief Financial Officer |
| Andrew Newbury CPA | Corporate Secretary |